Literature DB >> 27922185

Relaxin family peptides: structure-activity relationship studies.

Nitin A Patil1,2, K Johan Rosengren3, Frances Separovic2, John D Wade1,2, Ross A D Bathgate1,3, Mohammed Akhter Hossain1,2.   

Abstract

The human relaxin peptide family consists of seven cystine-rich peptides, four of which are known to signal through relaxin family peptide receptors, RXFP1-4. As these peptides play a vital role physiologically and in various diseases, they are of considerable importance for drug discovery and development. Detailed structure-activity relationship (SAR) studies towards understanding the role of important residues in each of these peptides have been reported over the years and utilized for the design of antagonists and minimized agonist variants. This review summarizes the current knowledge of the SAR of human relaxin 2 (H2 relaxin), human relaxin 3 (H3 relaxin), human insulin-like peptide 3 (INSL3) and human insulin-like peptide 5 (INSL5). LINKED ARTICLES: This article is part of a themed section on Recent Progress in the Understanding of Relaxin Family Peptides and their Receptors. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.10/issuetoc.
© 2016 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27922185      PMCID: PMC5406294          DOI: 10.1111/bph.13684

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  89 in total

Review 1.  The evolution of the relaxin peptide family and their receptors.

Authors:  Tracey N Wilkinson; Ross A D Bathgate
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

2.  Central relaxin-3 receptor (RXFP3) activation decreases anxiety- and depressive-like behaviours in the rat.

Authors:  Philip J Ryan; Elena Büchler; Fazel Shabanpoor; Mohammed Akhter Hossain; John D Wade; Andrew J Lawrence; Andrew L Gundlach
Journal:  Behav Brain Res       Date:  2013-02-01       Impact factor: 3.332

3.  Relaxin structure. Quasi allosteric effect of the NH2-terminal A-chain helix.

Authors:  E E Büllesbach; C Schwabe
Journal:  J Biol Chem       Date:  1987-09-15       Impact factor: 5.157

4.  Analogs of insulin-like peptide 3 (INSL3) B-chain are LGR8 antagonists in vitro and in vivo.

Authors:  Mark P Del Borgo; Richard A Hughes; Ross A D Bathgate; Feng Lin; Kazu Kawamura; John D Wade
Journal:  J Biol Chem       Date:  2006-03-17       Impact factor: 5.157

5.  The chemically synthesized human relaxin-2 analog, B-R13/17K H2, is an RXFP1 antagonist.

Authors:  Mohammed Akhter Hossain; Chrishan S Samuel; Claudia Binder; Tim D Hewitson; Geoffrey W Tregear; John D Wade; Ross A D Bathgate
Journal:  Amino Acids       Date:  2009-12-31       Impact factor: 3.520

Review 6.  Relaxin family peptides and their receptors.

Authors:  R A D Bathgate; M L Halls; E T van der Westhuizen; G E Callander; M Kocan; R J Summers
Journal:  Physiol Rev       Date:  2013-01       Impact factor: 37.312

7.  Engineering of a Novel Simplified Human Insulin-Like Peptide 5 Agonist.

Authors:  Nitin A Patil; Richard A Hughes; K Johan Rosengren; Martina Kocan; Sheng Yu Ang; Julien Tailhades; Frances Separovic; Roger J Summers; Johannes Grosse; John D Wade; Ross A D Bathgate; Mohammed Akhter Hossain
Journal:  J Med Chem       Date:  2016-02-12       Impact factor: 7.446

8.  Porcine relaxin: molecular cloning and cDNA structure.

Authors:  J Haley; P Hudson; D Scanlon; M John; M Cronk; J Shine; G Tregear; H Niall
Journal:  DNA       Date:  1982

9.  Evolution of the relaxin-like peptide family.

Authors:  Tracey N Wilkinson; Terence P Speed; Geoffrey W Tregear; Ross A D Bathgate
Journal:  BMC Evol Biol       Date:  2005-02-12       Impact factor: 3.260

10.  Elucidation of relaxin-3 binding interactions in the extracellular loops of RXFP3.

Authors:  Ross A D Bathgate; Maria H Y Oh; W J Jason Ling; Quentin Kaas; M Akhter Hossain; Paul R Gooley; K Johan Rosengren
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-22       Impact factor: 5.555

View more
  15 in total

Review 1.  Understanding Peptide Binding in Class A G Protein-Coupled Receptors.

Authors:  Irina G Tikhonova; Veronique Gigoux; Daniel Fourmy
Journal:  Mol Pharmacol       Date:  2019-07-10       Impact factor: 4.436

2.  Recent progress in the understanding of relaxin family peptides and their receptors.

Authors:  R J Summers
Journal:  Br J Pharmacol       Date:  2017-05       Impact factor: 8.739

Review 3.  Relaxin family peptides: structure-activity relationship studies.

Authors:  Nitin A Patil; K Johan Rosengren; Frances Separovic; John D Wade; Ross A D Bathgate; Mohammed Akhter Hossain
Journal:  Br J Pharmacol       Date:  2017-01-19       Impact factor: 8.739

4.  Distinct but overlapping binding sites of agonist and antagonist at the relaxin family peptide 3 (RXFP3) receptor.

Authors:  Lilian L L Wong; Daniel James Scott; Mohammed Akhter Hossain; Quentin Kaas; K Johan Rosengren; Ross A D Bathgate
Journal:  J Biol Chem       Date:  2018-08-21       Impact factor: 5.157

5.  Binding conformation and determinants of a single-chain peptide antagonist at the relaxin-3 receptor RXFP3.

Authors:  Linda M Haugaard-Kedström; Han Siean Lee; Maryon V Jones; Angela Song; Vishaal Rathod; Mohammed Akhter Hossain; Ross A D Bathgate; K Johan Rosengren
Journal:  J Biol Chem       Date:  2018-08-21       Impact factor: 5.157

Review 6.  Sexual Dimorphism and the Origins of Human Spinal Health.

Authors:  Vicente Gilsanz; Tishya A L Wren; Skorn Ponrartana; Stefano Mora; Clifford J Rosen
Journal:  Endocr Rev       Date:  2018-04-01       Impact factor: 19.871

7.  Optimization of the first small-molecule relaxin/insulin-like family peptide receptor (RXFP1) agonists: Activation results in an antifibrotic gene expression profile.

Authors:  Kenneth J Wilson; Jingbo Xiao; Catherine Z Chen; Zaohua Huang; Irina U Agoulnik; Marc Ferrer; Noel Southall; Xin Hu; Wei Zheng; Xin Xu; Amy Wang; Courtney Myhr; Elena Barnaeva; Emmett R George; Alexander I Agoulnik; Juan J Marugan
Journal:  Eur J Med Chem       Date:  2018-06-07       Impact factor: 6.514

8.  Transcriptional up-regulation of relaxin-3 by Nur77 attenuates β-adrenergic agonist-induced apoptosis in cardiomyocytes.

Authors:  Xiaohua You; Zhi-Fu Guo; Fang Cheng; Bing Yi; Fan Yang; Xinzhu Liu; Ni Zhu; Xianxian Zhao; Guijun Yan; Xin-Liang Ma; Jianxin Sun
Journal:  J Biol Chem       Date:  2018-07-13       Impact factor: 5.157

Review 9.  Structure-Activity Relationships of Insect Defensins.

Authors:  Johannes Koehbach
Journal:  Front Chem       Date:  2017-07-12       Impact factor: 5.221

10.  Development of a selective agonist for relaxin family peptide receptor 3.

Authors:  Dian Wei; Meng-Jun Hu; Xiao-Xia Shao; Jia-Hui Wang; Wei-Han Nie; Ya-Li Liu; Zeng-Guang Xu; Zhan-Yun Guo
Journal:  Sci Rep       Date:  2017-06-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.